Overview

Kenneth Weber, Ph.D., focuses his practice on patent prosecution, particularly in the areas of molecular genetics, chemistry, pharmaceuticals, plant and agricultural sciences, medical devices, and microbial genetics. He regularly assists clients in patent portfolio management, due diligence reviews, validity/infringement opinions and licensing.

Dr. Weber's clients include public and private corporations across the United States. Representative corporate clients include Aqua Bounty Technologies, University of Chicago and University of Texas, Grimmway Farms, Biosensors International Group, and Sun-Maid Growers. Representative clients in the bay area include Corcept Therapeutics, Kalobios Pharmaceuticals, Osel, and Sutro Biopharma.

Dr. Weber provides a unique, collaborative approach to creating patent strategies for companies with weak patent estates. Born out of years of evaluating startups for investors, and creating patent prosecution strategies for clients with repurposed drugs or non-inventive medical devices, Dr. Weber’s proactive legal counsel maximizes the opportunity to extract patentable inventions from routine experimentation and engineering work.

Dr. Weber was recognized in 2016, 2017 and 2018 by The Best Lawyers in America® for Biotechnology Law.

Current Professional Activities and Speeches
Teacher – Fundamentals of Patent Prosecution (2012 - Present)
Speaker – Amer. Soc. Exp. Neurotherapeutics /NIH Symposium (2014 - Present)
Speaker – BIO/LES Business Development Course (2011 - Present)
Speaker – Brown University - Patents and Startups (2014)
Speaker – Johns Hopkins Medical School – Patent Strategies for Repurposed and Rescued Drugs (2014)

More
Insights
Services
Industries
Education

University of Washington, J.D. (1984)

Oregon State University, Ph.D., Plant Pathology (1979)

State University of New York at Albany, B.S., Biology (1975)

Admissions

California (1988)

Court Admissions

U.S. Patent and Trademark Office

Professional & Community Activities

American Bar Association

American Intellectual Property Law Association

Latest Thinking

View more Insights
Insights Center
close
Loading...